11/13
04:30 pm
allo
Form 8-K Allogene Therapeutics, For: Nov 11
Medium
Report
Form 8-K Allogene Therapeutics, For: Nov 11
11/12
01:27 pm
allo
Form SC 13G/A Allogene Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Allogene Therapeutics, Filed by: VANGUARD GROUP INC
11/8
02:20 pm
allo
Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.
11/7
04:15 pm
allo
Form 10-Q Allogene Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Allogene Therapeutics, For: Sep 30
11/7
04:06 pm
allo
Form 8-K Allogene Therapeutics, For: Nov 07
Medium
Report
Form 8-K Allogene Therapeutics, For: Nov 07
11/4
10:57 am
allo
Form SC 13G Allogene Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G Allogene Therapeutics, Filed by: VANGUARD GROUP INC
10/23
04:22 pm
allo
Form 4 Allogene Therapeutics, For: Oct 21 Filed by: Parker Geoffrey M.
Medium
Report
Form 4 Allogene Therapeutics, For: Oct 21 Filed by: Parker Geoffrey M.
10/22
03:25 pm
allo
Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G/A Allogene Therapeutics, Filed by: BlackRock, Inc.
10/21
04:06 pm
allo
Form 144 Allogene Therapeutics, Filed by: Parker Geoffrey M.
Neutral
Report
Form 144 Allogene Therapeutics, Filed by: Parker Geoffrey M.
10/7
04:28 pm
allo
Form 8-K Allogene Therapeutics, For: Oct 03
Medium
Report
Form 8-K Allogene Therapeutics, For: Oct 03
8/23
04:15 pm
allo
Form 4 Allogene Therapeutics, For: Aug 21 Filed by: Douglas Earl Martin
Medium
Report
Form 4 Allogene Therapeutics, For: Aug 21 Filed by: Douglas Earl Martin